Alvotech

Alvotech is a specialty biopharmaceutical company dedicated to the development and manufacturing of high-quality biosimilar medicines. Founded in 2013 by Róbert Wessman in Reykjavík, the company aims to enhance patients' health and quality of life worldwide by increasing access to effective therapies for a range of ailments. Through its integrated approach, Alvotech focuses on providing proven treatments that address various diseases, thereby contributing to improved healthcare outcomes globally.

Top Sectors

Pharmaceuticals Biotechnology Therapeutics

Top Regions

Nordic Europe DACH Switzerland Scandinavia Central Europe Show more

http://www.alvotech.com

https://crunchbase.com/organization/alvotech

https://facebook.com/alvotechbiosimilars

https://linkedin.com/company/alvotech

https://pitchbook.com/profiles/company/146300-32

https://twitter.com/alvotech_bio

https://www.capitaliq.com/CIQDotNet/company.aspx?companyId=257527922

Róbert Wessman

Founder and Chairman

Hafrun Fridriksdottir Ph.D

COO, Operations

1 past transactions

Baliopharm

Acquisition in 2016

Baliopharm AG is a biotechnology company based in Basel, Switzerland, with a subsidiary in Jülich, Germany. Established in 2007, the company specializes in developing novel therapeutics aimed at treating immune-mediated inflammatory diseases, such as rheumatoid arthritis, Crohn's disease, psoriasis, and multiple sclerosis, as well as various cancers. Baliopharm's innovative approaches are designed to enhance treatment options for physicians and improve patient outcomes in these challenging medical conditions. As of 2018, Baliopharm operates as a subsidiary of PROMETHERA Biosciences S.A./N.V.

Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.